Search

everythinglearnresearchcommunity

for

Search:↓

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Men with androgenetic alopecia have lower levels of certain proteins and more cell damage.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

TNF-a may not be as involved in certain types of hair loss as previously thought.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Many young men with hair loss have low levels of vitamin D and B12.

COVID-19 can cause hair and nail disorders after infection.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 may cause temporary hair loss in some people.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Pigtail hair is a sign of new hair growth and should be recognized in hair loss conditions like acute telogen effluvium.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Early hair loss may indicate future prostate issues.

Dermoscopy is useful for diagnosing different types of hair loss.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Both trichoscopy and folliscopy accurately diagnose telogen effluvium, but trichoscopy is easier and faster.